Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Affiliation
Department of Anaesthesiology, Rotunda Hospital, Dublin, Ireland., gavin.weekes@gmail.comIssue Date
2012-02-01T10:38:12ZMeSH
AdultAndrostanols/adverse effects/*antagonists & inhibitors
Anesthesia, General
Anesthesia, Obstetrical
Cesarean Section
Female
Humans
Infant, Newborn
Male
Myelitis, Transverse/*complications
Neuromuscular Blockade/*adverse effects
Neuromuscular Nondepolarizing Agents/adverse effects/*antagonists & inhibitors
Paralysis/complications
Pregnancy
Pregnancy Complications/*therapy
gamma-Cyclodextrins/*therapeutic use
Metadata
Show full item recordCitation
Int J Obstet Anesth. 2010 Jul;19(3):333-6. Epub 2010 Jun 2.Journal
International journal of obstetric anesthesiaDOI
10.1016/j.ijoa.2010.03.009PubMed ID
20627694Abstract
A 38-year-old wheelchair-bound primigravida with transverse myelitis presented at 38 weeks of gestation for elective caesarean section. Transverse myelitis, which is characterised by bilateral inflammation of the spinal cord and myelin destruction, is associated with myopathy, autonomic dysreflexia and pulmonary aspiration. Regional anaesthesia was contraindicated in this case as the patient had undergone two previous lumbar spinal fusion procedures. Rocuronium 1.2 mg/kg was used to facilitate rapid intubating conditions. The caesarean section proceeded uneventfully, but even after administration of neostigmine the patient exhibited prolonged neuromuscular blockade. After 3 h and 15 min sugammadex was obtained to reverse neuromuscular blockade; the drug was not stocked in our hospital. Sugammadex 4 mg/kg resulted in complete reversal of blockade after 2 min. We believe that myopathy associated with transverse myelitis led to the prolonged duration of action of rocuronium. Sugammadex is a relatively new drug with few reported side effects. In this case it was used to reverse neuromuscular blockade and prevented prolonged postoperative ventilatory support.Language
engISSN
1532-3374 (Electronic)0959-289X (Linking)
ae974a485f413a2113503eed53cd6c53
10.1016/j.ijoa.2010.03.009
Scopus Count
Collections
Related articles
- Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
- Authors: Sacan O, White PF, Tufanogullari B, Klein K
- Issue date: 2007 Mar
- A novel approach to reversal of neuromuscular blockade.
- Authors: Della Rocca G, Pompei L
- Issue date: 2009 May
- Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
- Authors: de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M
- Issue date: 2007 Aug
- The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.
- Authors: White PF, Tufanogullari B, Sacan O, Pavlin EG, Viegas OJ, Minkowitz HS, Hudson ME
- Issue date: 2009 Mar
- Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
- Authors: Abrishami A, Ho J, Wong J, Yin L, Chung F
- Issue date: 2010 Apr 1